Vaccine having a peptide adjuvant for eliciting a specific immune response to treat viral infection and other conditions

Details for Australian Patent Application No. 2010282169 (hide)

Owner IMMUNOTECH DEVELOPMENTS INC.

Inventors Sahner, David; Lalonde, Guy

Agent Collison & Co

Pub. Number AU-A-2010282169

PCT Pub. Number WO2011/017799

Priority 61/232,618 10.08.09 US

Filing date 10 August 2010

Wipo publication date 17 February 2011

International Classifications

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

8 March 2012 PCT application entered the National Phase

  PCT publication WO2011/017799 Priority application(s): WO2011/017799

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010282170-Methods, compounds, and compositions for delivering 1,3-propan ed isulfonic acid

2010282167-Fractionation of a waste liquor stream from nanocrystalline cellulose production